Momenta Stops Rivals' Generic Lovenox Launch For Now

By Stewart Bishop · October 7, 2011, 7:38 PM EDT

Massachusetts drugmaker Momenta Pharmaceuticals Inc. said Friday that it had obtained a temporary restraining order against Amphastar Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and International Medical Systems Ltd. barring the rivals from...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Momenta Pharmaceuticals, Inc. et al v. Amphastar Pharmaceuticals, Inc. et al

Case Number

Court

Massachusetts

Nature of Suit

Patent

Date Filed

September 21, 2011

Recent Articles By Stewart

February 19, 2025
Ex-Perella Weinberg Partner Denies Plot To Split Firm
August 02, 2024
2nd Circ. Backs Conviction Over Fake-Therapy Scheme
March 08, 2024
DOJ Eyes FCPA For New Whistleblower Rewards Program
March 06, 2024
Ex-Stimwave CEO Found Guilty Of Healthcare Fraud
March 04, 2024
Trial Of Ex-Stimwave CEO Over Medical Device Nears End
February 29, 2024
Bankrupt Endo To Pay $465M To Resolve Opioid Claims
September 18, 2023
NYC Atty Admits To Bilking Clients, Laundering Fraud Funds
July 14, 2023
Colombo Family Union Shakedown Case Nets Final Plea
March 10, 2023
Ex-Congressman Stephen Buyer Convicted Of Insider Trading
March 09, 2023
Ex-Congressman Says Feds' Insider Trading Rap Is Weak